Precedex 4 ug/mL (Dexmedetomidine Hydrochloride INJECTION, SOLUTION) 4 ug/mL

Precedex 4 ug/mL is a Dexmedetomidine Hydrochloride injection used for sedation in intensive care units. This intravenous solution is manufactured by Hospira, Inc. in the USA.

Strength

4 ug/mL

Pack Size

20 BOTTLE in 1 TRAY (0409-1454-20) / 50 mL in 1 BOTTLE (0409-1454-01)

Manufacturer / TM Owner

Hospira, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Precedex 4 ug/mL is primarily used for sedation in mechanically ventilated adults in an intensive care setting. It is often administered to help patients remain calm and comfortable during medical procedures or recovery. The medication works by affecting certain areas of the brain to produce a sedative effect. What is Precedex used for? It is commonly used for short-term sedation and to help manage agitation in critically ill patients.

Side Effects

Common effects of Precedex 4 ug/mL may include low blood pressure, slow heart rate, and drowsiness. Some patients might experience nausea or vomiting. These effects are generally mild and temporary, but they can vary from person to person. It is important to monitor patients closely for any adverse reactions.

Precautions & Warnings

Precedex 4 ug/mL should be handled with care and administered by healthcare professionals. It is important to follow proper storage and handling guidelines to ensure the medication remains effective. Patients with a history of heart problems or low blood pressure should be monitored closely. Always consult a healthcare provider before use.

Avoid Interactions

Precedex 4 ug/mL may interact with other medications, including those that affect blood pressure or heart rate. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain sedatives may enhance the effects of Precedex, so caution is advised.

Frequently Asked Questions

Precedex is used for sedation in mechanically ventilated adults in intensive care settings.

Precedex is administered intravenously by healthcare professionals.

Common side effects may include low blood pressure, slow heart rate, and drowsiness.

Precedex is typically used for short-term sedation and should be administered under medical supervision.

Precedex is manufactured by Hospira, Inc. in the USA.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.